PATENT CLAIM ANALYSIS

Application Number: 15778046
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-02
Patent Classification: ["424", "204100"]

Abstract:
The invention features lentiviral transfer vectors that include heterologous nucleic acids to be introduced into a cell. The lentiviral transfer vector may be characterized by the following features: (a) including a cytomegalovirus (CMV) promoter; (b) including a polynucleotide encoding a partial gag protein that includes a mutated INS1 inhibitory sequence that reduces restriction of nuclear export of RNA; (c) not including a polynucleotide encoding the INS2, INS3, and INS4 inhibitory sequences of gag; (d) not including an SV40 origin of replication and/or an f1 origin of replication; (e) including a cPPT sequence that contains splice site; (f) including an EF1 alpha promoter with intact splice donor and acceptor sites; and (g) including hepatitis B PRE with mutation in start codon of X protein ORF.

Claim (Index 3):
The lentiviral transfer vector of  claim 1 , characterized by all of features (a)-(d).

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 1.73563
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15511973', '15866222', '14805236', '15105082', '14830392']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7787555943722484
- 35 USC 102 Novelty (BERT): 0.5417381901034649
- Combined Prediction Score: 0.7550538539453701
- Mean Citation Score: 378.912568
- Max Citation Score: 399.0973
- Similarity Product: 279.52862702266583

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test